InsidersTradesSigma
Follow the PFP share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, PFP has recorded 3 reports. Market capitalisation: €465m. The latest transaction was filed on 2 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. The full history is free.
Analysts rate PFP Buy (bullish), based on 6 analysts. Average price target: A$4.74.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
PFP是一家在XASX市场上市的健康和制药领域的公司。它专注于开发和商业化创新解决方案以改善医疗保健。